The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Papillomaviruses and cancer: from basic studies to clinical application
zur Hausen, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc798 · Cited by 4,024
Principles of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.-C., Valent, A., Minty, A., Chalon, P., Lelias, J.-M., Dumont, X., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80540-1 · Cited by 1,637
Paul Ehrlich's magic bullet concept: 100 years of progress
Strebhardt, K., & Ullrich, A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2394 · Cited by 1,457
Self-citationNolen, B., Taylor, S., & Ghosh, G. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.024 · Cited by 1,167
Polo-like kinases and the orchestration of cell division
Barr, F. A., Silljé, H. H. W., & Nigg, E. A. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1401 · Cited by 1,087
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
Luo, J., Emanuele, M. J., Li, D., Creighton, C. J., Schlabach, M. R., Westbrook, T. F., Wong, K.-K., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.05.006 · Cited by 1,017
Cell cycle kinases as therapeutic targets for cancer
Lapenna, S., & Giordano, A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2907 · Cited by 905
Targeting polo-like kinase 1 for cancer therapy
Strebhardt, K., & Ullrich, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1841 · Cited by 841
Self-citationBI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo
Steegmaier, M., Hoffmann, M., Baum, A., Lénárt, P., Petronczki, M., Krššák, M., Gürtler, U., Garin-Chesa, P., Lieb, S., Quant, J., et al. (2007) · Current Biology · doi:10.1016/j.cub.2006.12.037 · Cited by 834
FoxM1 is required for execution of the mitotic programme and chromosome stability
Laoukili, J., Kooistra, M. R. H., Brás, A., Kauw, J., Kerkhoven, R. M., Morrison, A., Clevers, H., & Medema, R. H. (2005) · Nature Cell Biology · doi:10.1038/ncb1217 · Cited by 807
The Polo kinase Plk4 functions in centriole duplication
Habedanck, R., Stierhof, Y.-D., Wilkinson, C. J., & Nigg, E. A. (2005) · Nature Cell Biology · doi:10.1038/ncb1320 · Cited by 804
Elia, A. E. H., Rellos, P., Haire, L. F., Chao, J. W., Ivins, F. J., Hoepker, K., Mohammad, D., Cantley, L. C., Smerdon, S. J., & Yaffe, M. B. (2003) · Cell · doi:10.1016/s0092-8674(03)00725-6 · Cited by 760
Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery
Macůrek, L., Lindqvist, A., Lim, D., Lampson, M. A., Klompmaker, R., Freire, R., Clouin, C., Taylor, S. S., Yaffe, M. B., & Medema, R. H. (2008) · Nature · doi:10.1038/nature07185 · Cited by 710
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy
Tovar, C., Rosinski, J., Filipovic, Z., Higgins, B., Kolinsky, K., Hilton, H., Zhao, X., Vu, B. T., Qing, W., Packman, K., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507493103 · Cited by 708
A Physical Map of 30,000 Human Genes
Deloukas, P., Schuler, G. D., Gyapay, G., Beasley, E. M., Soderlund, C., Rodriguez-Tomé, P., Hui, L., Matise, T. C., McKusick, K. B., Beckmann, J. S., et al. (1998) · Science · doi:10.1126/science.282.5389.744 · Cited by 704
Lane, H. A., & Nigg, E. A. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.6.1701 · Cited by 690
Proteomic Screen Finds pSer/pThr-Binding Domain Localizing Plk1 to Mitotic Substrates
Elia, A. E. H., Cantley, L. C., & Yaffe, M. B. (2003) · Science · doi:10.1126/science.1079079 · Cited by 684
Hanna, N., Bunn, P. A., Langer, C., Einhorn, L., Guthrie, T., Beck, T., Ansari, R., Ellis, P., Byrne, M., Morrison, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.8595 · Cited by 681
The genetics of the p53 pathway, apoptosis and cancer therapy
Vazquez, A., Bond, E. E., Levine, A. J., & Bond, G. L. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2656 · Cited by 676
Aurora-kinase inhibitors as anticancer agents
Keen, N., & Taylor, S. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1502 · Cited by 675
p53 polymorphisms: cancer implications
Whibley, C., Pharoah, P. D. P., & Hollstein, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2584 · Cited by 665
Meraldi, P. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.483 · Cited by 658
The Small-Molecule Inhibitor BI 2536 Reveals Novel Insights into Mitotic Roles of Polo-like Kinase 1
Lénárt, P., Petronczki, M., Steegmaier, M., Di Fiore, B., Lipp, J. J., Hoffmann, M., Rettig, W. J., Kraut, N., & Peters, J.-M. (2007) · Current Biology · doi:10.1016/j.cub.2006.12.046 · Cited by 653
MDM2 — master regulator of the p53 tumor suppressor protein
Momand, J., Wu, H.-H., & Dasgupta, G. (2000) · Gene · doi:10.1016/s0378-1119(99)00487-4 · Cited by 641
Wang, I.-C., Chen, Y.-J., Hughes, D., Petrovic, V., Major, M. L., Park, H. J., Tan, Y., Ackerson, T., & Costa, R. H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.10875-10894.2005 · Cited by 627
Bora and the Kinase Aurora A Cooperatively Activate the Kinase Plk1 and Control Mitotic Entry
Seki, A., Coppinger, J. A., Jang, C.-Y., Yates, J. R., & Fang, G. (2008) · Science · doi:10.1126/science.1157425 · Cited by 619
Active cyclin B1–Cdk1 first appears on centrosomes in prophase
Jackman, M., Lindon, C., Nigg, E. A., & Pines, J. (2003) · Nature Cell Biology · doi:10.1038/ncb918 · Cited by 612
Polo-like kinases: conservation and divergence in their functions and regulation
Archambault, V., & Glover, D. M. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2653 · Cited by 604
SAK/PLK4 Is Required for Centriole Duplication and Flagella Development
Bettencourt-Dias, M., Rodrigues-Martins, A., Carpenter, L., Riparbelli, M., Lehmann, L., Gatt, M. K., Carmo, N., Balloux, F., Callaini, G., & Glover, D. M. (2005) · Current Biology · doi:10.1016/j.cub.2005.11.042 · Cited by 600
Shugoshin collaborates with protein phosphatase 2A to protect cohesin
Kitajima, T. S., Sakuno, T., Ishiguro, K.-I., Iemura, S.-I., Natsume, T., Kawashima, S. A., & Watanabe, Y. (2006) · Nature · doi:10.1038/nature04663 · Cited by 597
Daub, H., Olsen, J. V., Bairlein, M., Gnad, F., Oppermann, F. S., Körner, R., Greff, Z., Kéri, G., Stemmann, O., & Mann, M. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.07.007 · Cited by 594
Polo, a mitotic mutant of Drosophila displaying abnormal spindle poles
Sunkel, C. E., & Glover, D. M. (1988) · Journal of Cell Science · doi:10.1242/jcs.89.1.25 · Cited by 561
Segregating Sister Genomes: The Molecular Biology of Chromosome Separation
Nasmyth, K. (2002) · Science · doi:10.1126/science.1074757 · Cited by 549
Purification and Molecular Cloning of Plx1, a Cdc25-Regulatory Kinase from Xenopus Egg Extracts
Kumagai, A., & Dunphy, W. G. (1996) · Science · doi:10.1126/science.273.5280.1377 · Cited by 507
Mishima, M., Kaitna, S., & Glotzer, M. (2002) · Developmental Cell · doi:10.1016/s1534-5807(01)00110-1 · Cited by 502
Characterization of the p53-Dependent Postmitotic Checkpoint following Spindle Disruption
Lanni, J. S., & Jacks, T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.1055 · Cited by 497
Polo on the Rise—from Mitotic Entry to Cytokinesis with Plk1
Petronczki, M., Lénárt, P., & Peters, J.-M. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.04.014 · Cited by 485
Cytokinesis: Placing and Making the Final Cut
Barr, F. A., & Gruneberg, U. (2007) · Cell · doi:10.1016/j.cell.2007.11.011 · Cited by 485
Targeted anti-mitotic therapies: can we improve on tubulin agents?
Jackson, J. R., Patrick, D. R., Dar, M. M., & Huang, P. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2049 · Cited by 473
Golsteyn, R. M., Mundt, K. E., Fry, A. M., & Nigg, E. A. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.6.1617 · Cited by 473
Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells
Liu, X., & Erikson, R. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031523100 · Cited by 472
M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCF β-TrCP
Watanabe, N., Arai, H., Nishihara, Y., Taniguchi, M., Watanabe, N., Hunter, T., & Osada, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307700101 · Cited by 472
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations
Li, Z., Lu, J., Sun, M., Mi, S., Zhang, H., Luo, R. T., Chen, P., Wang, Y., Yan, M., Qian, Z., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808266105 · Cited by 457
Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I
Riedel, C. G., Katis, V. L., Katou, Y., Mori, S., Itoh, T., Helmhart, W., Gálová, M., Petronczki, M., Gregan, J., Cetin, B., et al. (2006) · Nature · doi:10.1038/nature04664 · Cited by 455
The Dissociation of Cohesin from Chromosomes in Prophase Is Regulated by Polo-like Kinase
Sumara, I., Vorlaufer, E., Stukenberg, P. T., Kelm, O., Redemann, N., Nigg, E. A., & Peters, J.-M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00473-2 · Cited by 453
Polo-like kinase-1 is a target of the DNA damage checkpoint
Smits, V. A. J., Klompmaker, R., Arnaud, L., Rijksen, G., Nigg, E. A., & Medema, R. H. (2000) · Nature Cell Biology · doi:10.1038/35023629 · Cited by 440
Mitotic regulation of the human anaphase-promoting complex by phosphorylation
Kraft, C. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg627 · Cited by 425
Polo-like kinases: a team that plays throughout mitosis
Glover, D. M., Hagan, I. M., & Tavares, Á. A. M. (1998) · Genes & Development · doi:10.1101/gad.12.24.3777 · Cited by 424
Thymoquinone: A promising anti-cancer drug from natural sources
Gali-Muhtasib, H., Roessner, A., & Schneider-Stock, R. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.10.009 · Cited by 420
polo encodes a protein kinase homolog required for mitosis in Drosophila.
Llamazares, S., Moreira, A., Tavares, A., Girdham, C., Spruce, B. A., Gonzalez, C., Karess, R. E., Glover, D. M., & Sunkel, C. E. (1991) · Genes & Development · doi:10.1101/gad.5.12a.2153 · Cited by 404
Rudolph, D., Steegmaier, M., Hoffmann, M., Grauert, M., Baum, A., Quant, J., Haslinger, C., Garin-Chesa, P., & Adolf, G. R. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2445 · Cited by 398
Polo-like kinases (Plks) and cancer
Takai, N., Hamanaka, R., Yoshimatsu, J., & Miyakawa, I. (2005) · Oncogene · doi:10.1038/sj.onc.1208272 · Cited by 386
Ohkura, H., Hagan, I. M., & Glover, D. M. (1995) · Genes & Development · doi:10.1101/gad.9.9.1059 · Cited by 371
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
Gumireddy, K., Reddy, M. V. R., Cosenza, S. C., Nathan, R. B., Baker, S. J., Papathi, N., Jiang, J., Holland, J., & Reddy, E. P. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.009 · Cited by 367
Polo-like kinases and oncogenesis
Eckerdt, F., Yuan, J., & Strebhardt, K. (2005) · Oncogene · doi:10.1038/sj.onc.1208273 · Cited by 365
Self-citationFu, Z., Malureanu, L., Huang, J., Wang, W., Li, H., van Deursen, J. M., Tindall, D. J., & Chen, J. (2008) · Nature Cell Biology · doi:10.1038/ncb1767 · Cited by 355
Baumann, C., Körner, R., Hofmann, K., & Nigg, E. A. (2007) · Cell · doi:10.1016/j.cell.2006.11.041 · Cited by 354
Alexandru, G., Uhlmann, F., Mechtler, K., Poupart, M.-A., & Nasmyth, K. (2001) · Cell · doi:10.1016/s0092-8674(01)00362-2 · Cited by 353
Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice
Judge, A. D., Robbins, M., Tavakoli, I., Levi, J., Hu, L., Fronda, A., Ambegia, E., McClintock, K., & MacLachlan, I. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37515 · Cited by 336
Spankuch-Schmitt, B., Bereiter-Hahn, J., Kaufmann, M., & Strebhardt, K. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.24.1863 · Cited by 327
Self-citationPP2A Is Required for Centromeric Localization of Sgo1 and Proper Chromosome Segregation
Tang, Z., Shu, H., Qi, W., Mahmood, N. A., Mumby, M. C., & Yu, H. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.03.010 · Cited by 327
Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer
Wolf, G., Elez, R., Doermer, A., Holtrich, U., Ackermann, H., Stutte, H. J., Altmannsberger, H.-M., Rübsamen-Waigmann, H., & Strebhardt, K. (1997) · Oncogene · doi:10.1038/sj.onc.1200862 · Cited by 323
Self-citationPhosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis
Neef, R., Preisinger, C., Sutcliffe, J., Kopajtich, R., Nigg, E. A., Mayer, T. U., & Barr, F. A. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200306009 · Cited by 319
Elowe, S., Hümmer, S., Uldschmid, A., Li, X., & Nigg, E. A. (2007) · Genes & Development · doi:10.1101/gad.436007 · Cited by 312
Normal Cells, but Not Cancer Cells, Survive Severe Plk1 Depletion
Liu, X., Lei, M., & Erikson, R. L. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2093-2108.2006 · Cited by 303
Petronczki, M., Glotzer, M., Kraut, N., & Peters, J.-M. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.03.013 · Cited by 301
Polo-Like Kinases: A Team in Control of the Division
Weerdt, B. C. M. V. D., & Medema, R. H. (2006) · Cell Cycle · doi:10.4161/cc.5.8.2692 · Cited by 300
Sur, S., Pagliarini, R., Bunz, F., Rago, C., Diaz, L. A., Kinzler, K. W., Vogelstein, B., & Papadopoulos, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813333106 · Cited by 295
Cell cycle regulation of central spindle assembly
Mishima, M., Pavicic, V., Grüneberg, U., Nigg, E. A., & Glotzer, M. (2004) · Nature · doi:10.1038/nature02767 · Cited by 292
Regulation of Gene Expression at the Beginning of Mammalian Development
Nothias, J.-Y., Majumder, S., Kaneko, K. J., & DePamphilis, M. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22077 · Cited by 288
Holtrich, U., Wolf, G., Bräuninger, A., Karn, T., Böhme, B., Rübsamen-Waigmann, H., & Strebhardt, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1736 · Cited by 275
Self-citationMajor, M. L., Lepe, R., & Costa, R. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2649-2661.2004 · Cited by 266
Polo-like Kinase 1 (Plk1) Inhibits p53 Function by Physical Interaction and Phosphorylation
Ando, K., Ozaki, T., Yamamoto, H., Furuya, K., Hosoda, M., Hayashi, S., Fukuzawa, M., & Nakagawara, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314182200 · Cited by 264
Kitada, K., Johnson, A. L., Johnston, L. H., & Sugino, A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4445 · Cited by 263
Neef, R., Gruneberg, U., Kopajtich, R., Li, X., Nigg, E. A., Sillje, H., & Barr, F. A. (2007) · Nature Cell Biology · doi:10.1038/ncb1557 · Cited by 257
Proteomic screen defines the Polo‐box domain interactome and identifies Rock2 as a Plk1 substrate
Lowery, D. M., Clauser, K. R., Hjerrild, M., Lim, D., Alexander, J., Kishi, K., Ong, S., Gammeltoft, S., Carr, S. A., & Yaffe, M. B. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601683 · Cited by 257
Kang, Y. H., Park, J.-E., Yu, L.-R., Soung, N.-K., Yun, S.-M., Bang, J. K., Seong, Y.-S., Yu, H., Garfield, S., Veenstra, T. D., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.10.016 · Cited by 254
Cheng, K.-Y. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg558 · Cited by 254
Sütterlin, C., Hsu, P., Mallabiabarrena, A., & Malhotra, V. (2002) · Cell · doi:10.1016/s0092-8674(02)00720-1 · Cited by 252
Burkard, M. E., Randall, C. L., Larochelle, S., Zhang, C., Shokat, K. M., Fisher, R. P., & Jallepalli, P. V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701140104 · Cited by 251
Smith, M. R., Wilson, M. L., Hamanaka, R., Chase, D., Kung, H.-F., Longo, D. L., & Ferris, D. K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6633 · Cited by 248
Polo-like Kinase 1 Regulates Nlp, a Centrosome Protein Involved in Microtubule Nucleation
Casenghi, M., Meraldi, P., Weinhart, U., Duncan, P. I., Körner, R., & Nigg, E. A. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00193-x · Cited by 248
Lee, K. S., Grenfell, T. Z., Yarm, F. R., & Erikson, R. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9301 · Cited by 245
The in vivo gene expression signature of oxidative stress
Han, E.-S., Muller, F. L., Pérez, V. I., Qi, W., Liang, H., Xi, L., Fu, C., Doyle, E., Hickey, M., Cornell, J., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00239.2007 · Cited by 233
Inhibition of Polo-like Kinase 1 by Blocking Polo-Box Domain-Dependent Protein-Protein Interactions
Reindl, W., Yuan, J., Krämer, A., Strebhardt, K., & Berg, T. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.03.013 · Cited by 232
Self-citationKnecht, R., Elez, R., Oechler, M., Solbach, C., von Ilberg, C., & Strebhardt, K. (1999) · PubMed · Cited by 232
Self-citationAndrogen Receptor– and E2F-1–Targeted Thymoquinone Therapy for Hormone-Refractory Prostate Cancer
Kaseb, A. O., Chinnakannu, K., Chen, D., Sivanandam, A., Tejwani, S., Menon, M., Dou, Q. P., & Reddy, G. P.-V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1483 · Cited by 231
Polo-Like Kinase (PLK) Inhibitors in Preclinical and Early Clinical Development in Oncology
Schöffski, P. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0010 · Cited by 229
Xie, S., Wu, H., Wang, Q., Cogswell, J. P., Husain, I., Conn, C., Stambrook, P., Jhanwar-Uniyal, M., & Dai, W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106050200 · Cited by 227
Jang, Y.-J., Ma, S., Terada, Y., & Erikson, R. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202172200 · Cited by 219
Burns, T. F., Fei, P., Scata, K. A., Dicker, D. T., & El-Deiry, W. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5556-5571.2003 · Cited by 219
High-throughput kinase profiling as a platform for drug discovery
Goldstein, D. M., Gray, N. S., & Zarrinkar, P. P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2541 · Cited by 215
Roshak, A. K., Capper, E. A., Imburgia, C., Fornwald, J., Scott, G., & Marshall, L. A. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(00)00080-2 · Cited by 215
Moshe, Y., Boulaire, J., Pagano, M., & Hershko, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402442101 · Cited by 211
Seong, Y.-S., Kamijo, K., Lee, J.-S., Fernandez, E., Kuriyama, R., Miki, T., & Lee, K. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202602200 · Cited by 210
Hansen, D. V., Loktev, A. V., Ban, K. H., & Jackson, P. K. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-07-0598 · Cited by 208
Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis
Ko, M. A., Rosario, C. O., Hudson, J. W., Kulkarni, S., Pollett, A., Dennis, J. W., & Swallow, C. J. (2005) · Nature Genetics · doi:10.1038/ng1605 · Cited by 204
Kauselmann, G. (1999) · The EMBO Journal · doi:10.1093/emboj/18.20.5528 · Cited by 204
Mundt, K. E., Golsteyn, R. M., Lane, H. A., & Nigg, E. A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7378 · Cited by 200
Santamaria, A., Neef, R., Eberspächer, U., Eis, K., Husemann, M., Mumberg, D., Prechtl, S., Schulze, V., Siemeister, G., Wortmann, L., et al. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-05-0517 · Cited by 199
Functional studies on the role of the C-terminal domain of mammalian polo-like kinase
Jang, Y.-J., Lin, C.-Y., Ma, S., & Erikson, R. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042689299 · Cited by 195
Identification of an early-growth-response gene encoding a novel putative protein kinase.
Simmons, D. L., Neel, B. G., Stevens, R., Evett, G., & Erikson, R. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.9.4164 · Cited by 194
Topors Functions as an E3 Ubiquitin Ligase with Specific E2 Enzymes and Ubiquitinates p53
Rajendra, R., Malegaonkar, D., Pungaliya, P., Marshall, H., Rasheed, Z., Brownell, J., Liu, L. F., Lutzker, S., Saleem, A., & Rubin, E. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400300200 · Cited by 194
Burkard, M. E., Maciejowski, J., Rodriguez-Bravo, V., Repka, M., Lowery, D. M., Clauser, K. R., Zhang, C., Shokat, K. M., Carr, S. A., Yaffe, M. B., et al. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000111 · Cited by 192
Donohue, P. J., Alberts, G. F., Guo, Y., & Winkles, J. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.10351 · Cited by 191
Mahajan, S., Ghosh, S., Sudbeck, E. A., Zheng, Y., Downs, S., Hupke, M., & Uckun, F. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9587 · Cited by 191
Mitotic Activation of the Kinase Aurora-A Requires Its Binding Partner Bora
Hutterer, A., Berdnik, D., Wirtz-Peitz, F., Žigman, M., Schleiffer, A., & Knoblich, J. A. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.06.002 · Cited by 186
Topors acts as a SUMO‐1 E3 ligase for p53 in vitro and in vivo
Weger, S., Hammer, E., & Heilbronn, R. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.07.088 · Cited by 186
Complex formation of Plk1 and INCENP required for metaphase–anaphase transition
Goto, H., Kiyono, T., Tomono, Y., Kawajiri, A., Urano, T., Furukawa, K., Nigg, E. A., & Inagaki, M. (2006) · Nature Cell Biology · doi:10.1038/ncb1350 · Cited by 184
A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma
Salvatore, G., Nappi, T. C., Salerno, P., Jiang, Y., Garbi, C., Ugolini, C., Miccoli, P., Basolo, F., Castellone, M. D., Cirafici, A. M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1887 · Cited by 182
Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma
Weichert, W., Denkert, C., Schmidt, M., Gekeler, V, Wolf, G., Köbel, M., Dietel, M., & Hauptmann, S. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601610 · Cited by 177
Polo-like kinase 1 reaches beyond mitosis—cytokinesis, DNA damage response, and development
Takaki, T., Trenz, K., Costanzo, V., & Petronczki, M. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.10.005 · Cited by 176
Golan, A., Yudkovsky, Y., & Hershko, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111476200 · Cited by 172
Syljuåsen, R. G., Jensen, S., Bartek, J., & Lukas, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2144 · Cited by 168
Myosin Phosphatase-Targeting Subunit 1 Regulates Mitosis by Antagonizing Polo-like Kinase 1
Yamashiro, S., Yamakita, Y., Totsukawa, G., Goto, H., Kaibuchi, K., Ito, M., Hartshorne, D. J., & Matsumura, F. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.02.013 · Cited by 167
Khan, S. H., & Wahl, G. M. (1998) · PubMed · Cited by 166
Inhibition of Polo-like Kinase-1 by DNA Damage Occurs in an ATM- or ATR-dependent Fashion
van Vugt, M. A. T. M., Smits, V. A. J., Klompmaker, R., & Medema, R. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101831200 · Cited by 164
Plk1 regulates mitotic Aurora A function through βTrCP-dependent degradation of hBora
Chan, E. H. Y., Santamaria, A., Silljé, H. H. W., & Nigg, E. A. (2008) · Chromosoma · doi:10.1007/s00412-008-0165-5 · Cited by 160
Clay, F. J., McEwen, S. J., Bertoncello, I., Wilks, A. F., & Dunn, A. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4882 · Cited by 159
Phosphorylation by Cdk1 induces Plk1-mediated vimentin phosphorylation during mitosis
Yamaguchi, T., Goto, H., Yokoyama, T., Silljé, H. H. W., Hanisch, A., Uldschmid, A., Takai, Y., Oguri, T., Nigg, E. A., & Inagaki, M. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504091 · Cited by 159
Role of Plk2 ( Snk ) in Mouse Development and Cell Proliferation
Ma, S., Charron, J., & Erikson, R. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.19.6936-6943.2003 · Cited by 158
Mross, K., Frost, A., Steinbild, S., Hedbom, S., Rentschler, J., Kaiser, R., Rouyrre, N., Trommeshauser, D., Hoesl, C. E., & Munzert, G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.1547 · Cited by 158
Bahassi, E. M., Conn, C. W., Myer, D. L., Hennigan, R. F., McGowan, C. H., Sánchez, Y., & Stambrook, P. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205850 · Cited by 157
Qi, W., Tang, Z., & Yu, H. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-03-0240 · Cited by 157
Ahonen, L. J., Kallio, M. J., Daum, J. R., Bolton, M. A., Manke, I. A., Yaffe, M. B., Stukenberg, P. T., & Gorbsky, G. J. (2005) · Current Biology · doi:10.1016/j.cub.2005.05.026 · Cited by 156
The Plk1 target Kizuna stabilizes mitotic centrosomes to ensure spindle bipolarity
Oshimori, N., Ohsugi, M., & Yamamoto, T. S. (2006) · Nature Cell Biology · doi:10.1038/ncb1474 · Cited by 156
Polo-like Kinase 1 and Chk2 Interact and Co-localize to Centrosomes and the Midbody
Tsvetkov, L. M., Xu, X., Li, J., & Stern, D. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211202200 · Cited by 156
Late mitotic failure in mice lacking Sak, a polo-like kinase
Hudson, J. W., Kozarova, A., Cheung, P., Macmillan, J. C., Swallow, C. J., Cross, J. C., & Dennis, J. W. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00117-8 · Cited by 152
Different Plk1 Functions Show Distinct Dependencies on Polo-Box Domain-mediated Targeting
Hanisch, A., Wehner, A., Nigg, E. A., & Silljé, H. H. W. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-08-0801 · Cited by 151
Polo-like Kinase-2 Is Required for Centriole Duplication in Mammalian Cells
Warnke, S., Kemmler, S., Hames, R. S., Tsai, H.-L., Hoffmann‐Rohrer, U., Fry, A. M., & Hoffmann, I. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.059 · Cited by 150
Spänkuch, B., Wolf, G., Solbach, C., Loibl, S., Knecht, R., Stegmüller, M., von Minckwitz, G., Kaufmann, M., & Strebhardt, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205412 · Cited by 149
Self-citationGuan, R., Tapang, P., Leverson, J. D., Albert, D., Giranda, V. L., & Luo, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2131 · Cited by 148
Polo-Like Kinase 1 Is Essential for Early Embryonic Development and Tumor Suppression
Lu, L., Wood, J. L., Minter‐Dykhouse, K., Ye, L., Saunders, T. L., Yu, X., & Chen, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00392-08 · Cited by 148
Li, B., Ouyang, B., Pan, H., Reissmann, P. T., Slamon, D. J., Arceci, R. J., Lu, L., & Dai, W. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19402 · Cited by 145
The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localization
Leung, G. C., Hudson, J. W., Kozarova, A., Davidson, A. R., Dennis, J. W., & Sicheri, F. (2002) · Nature Structural Biology · doi:10.1038/nsb848 · Cited by 141
Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications
Weichert, W., Kristiansen, G., Winzer, K., Schmidt, M., Gekeler, V., Noske, A., Müller, B., Niesporek, S., Dietel, M., & Denkert, C. (2005) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-005-1212-8 · Cited by 141
In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1
Lansing, T. J., McConnell, R. T., Duckett, D. R., Spehar, G. M., Knick, V. B., Hassler, D. F., Noro, N., Furuta, M., Emmitte, K. A., Gilmer, T. M., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0543 · Cited by 140
Xie, S., Wang, Q., Wu, H., Cogswell, J. P., Luo, L., Jhanwar‐Uniyal, M., & Dai, W. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104157200 · Cited by 137
Plk1- and β-TrCP–dependent degradation of Bora controls mitotic progression
Seki, A., Coppinger, J. A., Du, H., Jang, C., Yates, J. R., & Fang, G. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200712027 · Cited by 136
Polo-Like Kinase Controls Vertebrate Spindle Elongation and Cytokinesis
Brennan, I. M., Peters, U., Kapoor, T. M., & Straight, A. F. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000409 · Cited by 136
Research Article: Selectivity‐determining Residues in Plk1
Kothe, M., Kohls, D., Low, S., Coli, R., Rennie, G. R., Féru, F., Kuhn, C. F., & Ding, Y. (2007) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00594.x · Cited by 131
Tang, J., Erikson, R. L., & Liu, X. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604987103 · Cited by 129
Microarray analysis of radiation response genes in primary human fibroblasts
Kis, E., Szatmári, T., Keszei, M., Farkas, R., Ésik, O., Lumniczky, K., Falus, A., & Sáfrány, G. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.08.004 · Cited by 129
Transcriptional silencing of Polo-like kinase 2(SNK/PLK2)is a frequent event in B-cell malignancies
Syed, N., Smith, P., Sullivan, A., Spender, L. C., Dyer, M. J. S., Karran, L., O’Nions, J., Allday, M. J., Hoffmann, I., Crawford, D., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1194 · Cited by 129
Jimeno, A., Li, J., Messersmith, W. A., Laheru, D. A., Rudek, M. A., Maniar, M. L., Hidalgo, M. M., Baker, S. D., & Donehower, R. C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9788 · Cited by 128
Nimer, S. D., & Golde, D. W. (1987) · Blood · doi:10.1182/blood.v70.6.1705.1705 · Cited by 128
Pandrea, I., & LANDAY, A. L. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-387715-4.00003-4 · Cited by 128
Yang, Y., Bai, J., Shen, R. Z., Brown, S. A. N., Komissarova, E. V., Huang, Y., Jiang, N., Alberts, G. F., Costa, M., Luo, L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6182 · Cited by 126
Probing cell-division phenotype space and Polo-like kinase function using small molecules
Peters, U., Cherian, J., Kim, J. H., Kwok, B. H. B., & Kapoor, T. M. (2006) · Nature Chemical Biology · doi:10.1038/nchembio826 · Cited by 125
Wang, Q., Xie, S., Chen, J., Fukasawa, K., Naik, U. P., Traganos, F., Darżynkiewicz, Z., Jhanwar‐Uniyal, M., & Dai, W. H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3450-3459.2002 · Cited by 124
Yuan, J., Eckerdt, F., Bereiter‐Hahn, J., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1206011 · Cited by 122
Comparative Expression of the Mitotic Regulators SAK and PLK in Colorectal Cancer
Macmillan, J. C., Hudson, J. W., Bull, S. B., Dennis, J. W., & Swallow, C. J. (2001) · Annals of Surgical Oncology · doi:10.1007/s10434-001-0729-6 · Cited by 121
Johnson, E. F., Stewart, K. D., Woods, K. W., Giranda, V. L., & Luo, Y. (2007) · Biochemistry · doi:10.1021/bi7008745 · Cited by 118
Polo-like kinase, a novel marker for cellular proliferation.
Yuan, J., Hörlin, A., Hock, B., Stutte, H. J., Rübsamen‐Waigmann, H., & Strebhardt, K. (1997) · Europe PMC (PubMed Central) · Cited by 117
Self-citationGarcía‐Álvarez, B., de Cárcer, G., Ibañez, S., Bragado‐Nilsson, E., & Montoya, G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609131104 · Cited by 117
5q-, twenty-five years later: a Synopsis
BERGHE, H. V. D., & Michaux, L. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00350-0 · Cited by 116
Human Prk Is a Conserved Protein Serine/Threonine Kinase Involved in Regulating M Phase Functions
Ouyang, B., Pan, H., Lu, L., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28646 · Cited by 111
Deficiency in Chromosome Congression by the Inhibition of Plk1 Polo Box Domain-dependent Recognition
Watanabe, N., Sekine, T., Takagi, M., Iwasaki, J.-I., Imamoto, N., Kawasaki, H., & Osada, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805308200 · Cited by 111
Progress in the Discovery of Polo-like Kinase Inhibitors
McInnes, C., Mezna, M., & Fischer, P. M. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026053507660 · Cited by 111
Staib, F., Robles, A. I., Varticovski, L., Wang, X. W., Zeebèrg, B. R., Sirotin, M., Zhurkin, V. B., Hofseth, L. J., Hussain, S. P., Weinstein, J. N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1714 · Cited by 103
Schuurmans, C. J., Motro, B., Yousefi, S., Heffernan, M. J., & Dennis, J. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6388 · Cited by 101
Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function.
Cogswell, J. P., Brown, C. E., Bisi, J., & Neill, S. D. (2000) · PubMed · Cited by 101
Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance
McInnes, C., Mazumdar, A., Mezna, M., Meades, C. K., Midgley, C., Scaërou, F., Carpenter, L., Mackenzie, M., Taylor, P., Walkinshaw, M. D., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio825 · Cited by 99
Casenghi, M., Barr, F. A., & Nigg, E. A. (2005) · Journal of Cell Science · doi:10.1242/jcs.02622 · Cited by 97
Cell Cycle-regulated Phosphorylation of the XenopusPolo-like Kinase Plx1
Kelm, O., Wind, M., Lehmann, W. D., & Nigg, E. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202855200 · Cited by 95
Lee, M.-Y., Daniels, M. J., & Venkitaraman, A. R. (2003) · Oncogene · doi:10.1038/sj.onc.1207223 · Cited by 93
Polo-like kinase 3 is required for entry into S phase
Zimmerman, W., & Erikson, R. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610856104 · Cited by 93
Patel, D., Incassati, A., Wang, N., & McCance, D. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2917 · Cited by 93
Incassati, A., Patel, D., & McCance, D. J. (2005) · Oncogene · doi:10.1038/sj.onc.1209276 · Cited by 92
Steinhauser, I. M., Langer, K., Strebhardt, K., & Spänkuch, B. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.001 · Cited by 90
Self-citationPlk1-mediated Phosphorylation of Topors Regulates p53 Stability
Yang, X., Li, H., Zhou, Z., Wang, W., Deng, A., ANDRISANI, O. M., & Liu, X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c109.001560 · Cited by 90
Lin, H.-R., Ting, N. S. Y., Qin, J., & Lee, W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210659200 · Cited by 86
Beria, I., Ballinari, D., Bertrand, J. A., Borghi, D., Bossi, R. T., Brasca, M. G., Cappella, P., Caruso, M., Ceccarelli, W., Ciavolella, A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901713n · Cited by 86
Overexpression of Polo-Like Kinase 1 (PLK1) and Chromosomal Instability in Bladder Cancer
Yamamoto, Y., Matsuyama, H., Kawauchi, S., Matsumoto, H., Nagao, K., Ohmi, C., Sakano, S., Furuya, T., Oga, A., Naito, K., et al. (2006) · Oncology · doi:10.1159/000094416 · Cited by 86
The novel mouse Polo-like kinase 5 responds to DNA damage and localizes in the nucleolus
Andrysík, Z., Bernstein, W. Z., Deng, L., Myer, D. L., Li, Y., Tischfield, J. A., Stambrook, P. J., & Bahassi, E. M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq011 · Cited by 86
Kitada, K., Johnson, A. L., Johnston, L. H., et al. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4445-4457.1993 · Cited by 86
Preferential cleavage of chromatin‐bound cohesin after targeted phosphorylation by Polo‐like kinase
Hornig, N., & Uhlmann, F. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600303 · Cited by 83
Li, J., Tan, M., Li, L., Pamarthy, D., Lawrence, T. S., & Sun, Y. (2005) · Neoplasia · doi:10.1593/neo.04325 · Cited by 82
The Polo‐like kinase Plx1 interacts with and inhibits Myt1 after fertilization of Xenopus eggs
Inoue, D., & Sagata, N. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600567 · Cited by 81
Conn, C. W., Hennigan, R. F., Dai, W. H., Sánchez, Y., & Stambrook, P. J. (2000) · PubMed · Cited by 81
Garland, L. L., Taylor, C., Pilkington, D., Cohen, J. L., & Hoff, D. D. V. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0214 · Cited by 80
Eckerdt, F., & Strebhardt, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0358 · Cited by 77
Self-citationConstitutive Expression of Murine Sak-a Suppresses Cell Growth and Induces Multinucleation
Schuurmans, C. J., Binkert, C., & Dennis, J. W. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4665 · Cited by 76
Polo-like Kinase 1 Is Involved in Invasion through Extracellular Matrix
Rizki, A., Mott, J. D., & Bissell, M. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2348 · Cited by 75
Zhou, T., Chou, J. W., Simpson, D. A., Zhou, Y., Mullen, T. E., Medeiros, M., Bushel, P. R., Paules, R. S., Yang, X., Hurban, P., et al. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.8026 · Cited by 74
Farnet, C. M., Wang, B., Hansen, M. S. T., Lipford, J. R., Zalkow, L. H., Robinson, W. E., Siegel, J. S., & Bushman, F. D. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2245 · Cited by 74
Polo-Like Kinase 1: Target and Regulator of Transcriptional Control
Martin, B. T., & Strebhardt, K. (2006) · Cell Cycle · doi:10.4161/cc.5.24.3538 · Cited by 72
Self-citationA novel treatment strategy targeting polo-like kinase 1 in hematological malignancies
Ikezoe, T., Yang, J., Nishioka, C., et al. (2009) · Leukemia · doi:10.1038/leu.2009.94 · Cited by 71
Reindl, W., Yuan, J., Krämer, A., Strebhardt, K., & Berg, T. (2009) · ChemBioChem · doi:10.1002/cbic.200900059 · Cited by 69
Self-citationPRK, a cell cycle gene localized to 8p21, is downregulated in head and neck cancer
Dai, W. H., Li, Y., Ouyang, B., Pan, H., Reissmann, P. T., Li, J., Wiest, J. S., Stambrook, P. J., Gluckman, J. L., Noffsinger, A. E., et al. (2000) · Genes Chromosomes and Cancer · Cited by 67
López-Sánchez, I., Sanz-García, M., & Lazo, P. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01341-08 · Cited by 64
Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages
Holtrich, U., Wolf, G., Yuan, J., Bereiter‐Hahn, J., Karn, T., Weiler, M., Kauselmann, G., Rehli, M., Andreesen, R., Kaufmann, M., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203845 · Cited by 63
Self-citationRestarting the Cell Cycle When the Checkpoint Comes to a Halt
van Vugt, M. A. T. M., Bràs, A., & Medema, R. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1054 · Cited by 63
Progress in the evaluation of CDK inhibitors as anti-tumor agents
McInnes, C. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.06.012 · Cited by 62
Kanaji, S., Saito, H., Tsujitani, S., Matsumoto, S., Tatebe, S., Kondo, A., Ozaki, M., Ito, H., & Ikeguchi, M. (2006) · Oncology · doi:10.1159/000093003 · Cited by 62
Ma, S., Liu, M.-A., Yuan, Y.-L. O., & Erikson, R. L. (2003) · PubMed · Cited by 62
Cited by
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Muller, P. A. J., & Vousden, K. H. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.021 · Cited by 1,545
Targeting Mitosis in Cancer: Emerging Strategies
Dominguez-Brauer, C., Thu, K. L., Mason, J. M., Blaser, H., Bray, M. R., & Mak, T. W. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.11.006 · Cited by 495
Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma
Chaisaingmongkol, J., Budhu, A., Dang, H., Rabibhadana, S., Pupacdi, B., Kwon, S. M., Forgues, M., Pomyen, Y., Bhudhisawasdi, V., Lertprasertsuke, N., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.009 · Cited by 434
Jansen, F., Yang, X., Hoelscher, M., Cattelan, A., Schmitz, T., Proebsting, S., Wenzel, D., Vosen, S., Franklin, B. S., Fleischmann, B. K., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001720 · Cited by 430
From Plk1 to Plk5: Functional evolution of polo-like kinases
de Cárcer, G., Manning, G., & Malumbres, M. (2011) · Cell Cycle · doi:10.4161/cc.10.14.16494 · Cited by 273
Metadata
- Authors
- Strebhardt, K.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-08
- Volume
- 9
- Issue
- 8
- Pages
- 643-660
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2037874673
- Cited by
- 653
- References
- 223
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.